IBNAX
Price
$23.95
Change
+$0.03 (+0.13%)
Updated
May 30 closing price
Net Assets
1.55B
RLBEX
Price
$35.32
Change
+$0.03 (+0.09%)
Updated
May 30 closing price
Net Assets
241.02B
Interact to see
Advertisement

IBNAX vs RLBEX

Header iconIBNAX vs RLBEX Comparison
Open Charts IBNAX vs RLBEXBanner chart's image
Macquarie Balanced Fund
Price$23.95
Change+$0.03 (+0.13%)
VolumeN/A
Net Assets1.55B
American Funds American Balanced R4
Price$35.32
Change+$0.03 (+0.09%)
VolumeN/A
Net Assets241.02B
IBNAX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IBNAX vs. RLBEX commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNAX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 241B vs. IBNAX (1.55B). RLBEX pays higher dividends than IBNAX: RLBEX (1.90) vs IBNAX (0.98). IBNAX was incepted earlier than RLBEX: IBNAX (38 years) vs RLBEX (23 years). IBNAX (1.08) is less costly to investors than RLBEX (0.59). IBNAX is a more actively managed with annual turnover of: 73.00 vs. RLBEX (44.00). RLBEX has a lower initial minimum investment than IBNAX: RLBEX (250) vs IBNAX (1000). IBNAX annual gain was more profitable for investors over the last year : 10.37 vs. RLBEX (7.62). RLBEX return over 5 years is better than : 36.91 vs. IBNAX (9.07).
IBNAXRLBEXIBNAX / RLBEX
Total Expense Ratio1.060.59180%
Annual Report Gross Expense Ratio1.080.59183%
Fund Existence38 years23 years-
Gain YTD2.0173.38160%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B241B1%
Annual Yield % from dividends0.981.9051%
Returns for 1 year10.377.62136%
Returns for 3 years5.0620.9724%
Returns for 5 years9.0736.9125%
Returns for 10 years1.1857.372%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PX10.860.06
+0.53%
P10
IX21.260.08
+0.38%
Orix Corp
KFS12.86-0.13
-1.00%
Kingsway Financial Services
LEXX1.01-0.02
-2.42%
Lexaria Bioscience Corp
SRPT37.60-1.01
-2.62%
Sarepta Therapeutics